IAS 2023, the 12th IAS Conference on HIV Science
Daily Statin Reduces CV Events by 35% Among Adults With HIV
The risk for CVD in people living with HIV can be 50% to 100% greater than those without HIV.
AUGUST 7, 2023
Can JAK Inhibitors Decrease HIV Viral Reservoirs?
Janus kinase inhibitors, specifically ruxolitinib, may significantly decay the viral reservoir of people with HIV, ...
AUGUST 7, 2023
Oral Bridging of Lenacapavir Maintains Viral Suppression Among HIV Patients
Oral bridging of lenacapavir enabled patients to maintain viral suppression of their HIV after missed doses of ...
JULY 26, 2023
Cisgender Women in 7 African Countries Prefer Long-Acting Cabotegravir PrEP
Nearly eight out of 10 cisgender women preferred long-acting injectable cabotegravir to daily oral pre-exposure ...
JULY 26, 2023
Load more